In this study, an injectable thermoresponsive
hydroxypropyl guar-graft-poly(N-vinylcaprolactam)
(HPG-g-PNVCL) copolymer was synthesized by graft
polymerization.
The reaction parameters such as temperature, time, monomer, and initiator
concentrations were varied. In addition, the HPG-g-PNVCL copolymer was modified with nano-hydroxyapatite (n-HA) by
in situ covalent cross-linking using divinyl sulfone (DVS) cross-linker
to obtain HPG-g-PNVCL/n-HA/DVS composite material.
Grafted copolymer and composite materials were characterized using
Fourier transform infrared spectroscopy, thermogravimetric analysis,
proton nuclear magnetic resonance spectroscopy (1H NMR),
and differential scanning calorimetry. The morphology of the grafted
copolymer (HPG-g-PNVCL) and the composite (HPG-g-PNVCL/n-HA/DVS) was examined using scanning electron microscopy
(SEM), which showed interconnected porous honeycomb-like structures.
Using Ultraviolet−visible spectroscopy, low critical solution
temperature for HPG-g-PNVCL was observed at 34 °C,
which is close to the rheology gel point at 33.5 °C. The thermoreversibility
of HPG-g-PNVCL was proved by rheological analysis.
The HPG-g-PNVCL hydrogel was employed for slow release
of the drug molecule. Ciprofloxacin, a commonly known antibiotic,
was used for sustainable release from the HPG-g-PNVCL
hydrogel as a function of time at 37 °C because of viscous nature
and thermogelation of the copolymer. In vitro cytotoxicity study reveals
that the HPG-g-PNVCL thermogelling polymer works
as a biocompatible scaffold for osteoblastic cell growth. Additionally,
in vitro biomineralization study of HPG-g-PNVCL/n-HA/DVS
was conducted using a simulated body fluid, and apatite-like structure
formation was observed by SEM.